
X
First patient dosed in trial of Allergan/Editas’ CRISPR blindness drug
https://pharmaphorum.com/news/first-patient-dosed-in-trial-of-allergan-editas-crispr-blindness-drug/
As Rare Disease Day approaches on 28 February, Santhera has created an infographic explaining the signs and symptoms of the rare disease Leber’s hereditary optic neuropathy (LHON), a progressive eye disease that results in blindness.
Review of Second Sight’s Orion will now be streamlined.
LHON is a frequently misdiagnosed condition that needs faster diagnosis.
Company gains $18 million in funding.
The Orcam My Eye improves performance in daily tasks such as reading and writing.